Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

SHE:300318 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	799.74	817.05	998.91	751.6	682.18	723.17
Other Revenue	34.64	34.64	46.52	44.33	32.57	15.54
Revenue	834.38	851.69	1,045	795.93	714.75	738.72
Revenue Growth (YoY)	-5.76%	-18.53%	31.35%	11.36%	-3.25%	17.57%
Cost of Revenue	496.77	434.16	593.97	542.42	422.28	385.56
Gross Profit	337.61	417.53	451.46	253.51	292.47	353.16
Selling, General & Admin	256.3	286	306.15	269.64	308.94	265.39
Research & Development	49.84	52.52	69.2	64.78	81.48	48.18
Other Operating Expenses	21.72	14.45	15.84	15.96	13.41	11.3
Operating Expenses	330.05	354.68	392.5	352.67	404.44	326.96
Operating Income	7.56	62.86	58.97	-99.16	-111.98	26.21
Interest Expense	-31.8	-28.96	-27.62	-42.25	-45.06	-35.44
Interest & Investment Income	0.64	1.92	4.78	0.51	4.97	5.49
Currency Exchange Gain (Loss)	-1.29	-1.29	-0.45	-1.07	-0.45	-0.01
Other Non Operating Income (Expenses)	-22.99	-6.42	-8.74	-6.79	-3.98	0.82
EBT Excluding Unusual Items	-47.88	28.1	26.94	-148.76	-156.5	-2.93
Impairment of Goodwill	-	-	-	-15.92	-340.68	-0.32
Gain (Loss) on Sale of Investments	-1.5	-	-	-	-	0.09
Gain (Loss) on Sale of Assets	-4.27	0.12	1.11	31.97	0.14	0.19
Asset Writedown	0.75	-2.55	-3.31	-1.61	-20.43	-0.16
Other Unusual Items	-46.2	-5.76	8.98	0.55	13.29	3.72
Pretax Income	-99.1	19.91	33.73	-133.78	-504.18	0.59
Income Tax Expense	-1.31	11.23	18.05	4.39	1.61	8.14
Earnings From Continuing Operations	-97.78	8.68	15.68	-138.17	-505.79	-7.55
Minority Interest in Earnings	49.7	0.57	-40.61	59.73	183.61	15.06
Net Income	-48.09	9.25	-24.93	-78.44	-322.18	7.5
Net Income to Common	-48.09	9.25	-24.93	-78.44	-322.18	7.5
Net Income Growth	-	-	-	-	-	195.11%
Shares Outstanding (Basic)	818	818	817	817	817	816
Shares Outstanding (Diluted)	818	818	817	817	817	816
Shares Change (YoY)	0.05%	0.11%	0.03%	0.03%	0.15%	-0.56%
EPS (Basic)	-0.06	0.01	-0.03	-0.10	-0.39	0.01
EPS (Diluted)	-0.06	0.01	-0.03	-0.10	-0.39	0.01
EPS Growth	-	-	-	-	-	196.77%
Free Cash Flow	-292.71	-227.64	-60.53	-120.74	-366.17	-116.2
Free Cash Flow Per Share	-0.36	-0.28	-0.07	-0.15	-0.45	-0.14
Gross Margin	40.46%	49.02%	43.18%	31.85%	40.92%	47.81%
Operating Margin	0.91%	7.38%	5.64%	-12.46%	-15.67%	3.55%
Profit Margin	-5.76%	1.09%	-2.38%	-9.86%	-45.08%	1.02%
Free Cash Flow Margin	-35.08%	-26.73%	-5.79%	-15.17%	-51.23%	-15.73%
EBITDA	95.74	156	158.74	6.53	-7.09	116.13
EBITDA Margin	11.47%	18.32%	15.18%	0.82%	-0.99%	15.72%
D&A For EBITDA	88.18	93.15	99.77	105.69	104.89	89.93
EBIT	7.56	62.86	58.97	-99.16	-111.98	26.21
EBIT Margin	0.91%	7.38%	5.64%	-12.46%	-15.67%	3.55%
Effective Tax Rate	-	56.41%	53.51%	-	-	1390.93%
Revenue as Reported	834.38	851.69	1,045	795.93	714.75	738.72
Advertising Expenses	-	15.2	17.36	14.71	31.57	47.49

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.